Instanyl

Drug selection of rapid acting fentanyl formulations in the treatment of breakthrough pain in patients with cancer is performed… Expand

PurposeInstanyl® (intranasal fentanyl spray) is a novel treatment for breakthrough pain (BTP) in cancer patients. It has shown a… Expand

Objective: Breakthrough cancer pain (BTcP) affects 19-95% of cancer patients (dependent on the definition and methods used and… Expand

• Among the eligible questionnaires: All were adult 58.8% declared having cancer 81.6% maintenance opioid therapy 39.0% using the… Expand

Opioids are considered important analgesics in the treatment armamentarium for moderate-to-severe background cancer pain. The… Expand

Objective: Determine, with a pharmacoeconomic evaluation, the effectiveness and efficiency of fentanyl pectin intranasal spray… Expand

The nasal cavity has for more than three decades been widely explored as a potential alternative route to oral or parenteral… Expand

1 Polyclinique de l’Ormeau, Tarbes. 2 Hôpital André-Mignot, Le Chesnay. 3 Institut Paoli-Calmette, Marseille. 4 CH de Bayeux. 5… Expand

Fentanyl, a potent opioid analgesic, is rapidly and efficiently absorbed from the nasal cavity, giving significant potential for… Expand

Oral normal-release morphine has long been considered the gold-standard treatment for cancer breakthrough pain. However, its… Expand